OCT引导下序贯激光光凝治疗中心凹周围视网膜母细胞瘤的视力与视觉潜能
该回顾性研究评估了OCT引导下从抗中心凹肿瘤边缘向内序贯激光光凝治疗中心凹周围视网膜母细胞瘤的肿瘤控制、视力及解剖视觉潜能。近中心凹肿瘤无复发,多数保留中心凹凹及≥500微米无肿瘤视网膜;中心凹肿瘤解剖和功能结局均显著更差。
要点
- 近中心凹视网膜母细胞瘤经OCT引导保中心凹激光治疗后无肿瘤复发。
- 近中心凹肿瘤眼解剖成功率高,中心凹肿瘤眼解剖失败率和复发率显著更高。
- 可接受视力在近中心凹眼达12/14,中心凹眼仅5/8,差异显著。
核心结论
- OCT引导下保中心凹激光光凝治疗近中心凹视网膜母细胞瘤的解剖视觉潜能和功能视力优于中心凹肿瘤。
研究设计与样本
- 回顾性综述2011年1月1日至2017年5月31日期间化疗后接受激光治疗的近中心凹或中心凹视网膜母细胞瘤眼。
- 每次治疗时用OCT监测肿瘤控制及中心凹和中心凹周围解剖,当另一眼视力更好时治疗弱视。
主要发现
- 近中心凹肿瘤无复发,13/14例患者保留中心凹凹且≥500微米中心凹周围视网膜无肿瘤。
- 中心凹肿瘤解剖结局显著更差:8/8眼未能恢复中心凹凹或中心凹周围视网膜(p=0.001),5/8眼肿瘤复发(p=0.001)。
- 功能成功(可接受视力>0.1小数)在近中心凹眼为12/14,中心凹眼为5/8(p=0.01)。
- 弱视治疗数据不足以评估其对视力的影响。
关键数值与推荐
- 近中心凹肿瘤定义为中心凹无肿瘤但距肿瘤边缘<3000微米;中心凹肿瘤定义为肿瘤位于中心凹下。
- 解剖成功定义为保留和/或恢复中心凹凹且≥500微米中心凹周围视网膜无肿瘤和瘢痕。
- 功能成功定义为可接受视力(>0.1小数)或良好视力(>0.3小数)。
临床怎么用
- 对近中心凹视网膜母细胞瘤可采用OCT引导下从抗中心凹肿瘤边缘向内序贯激光光凝,避免治疗靠近中心凹。
- 治疗中每 session 用OCT监测中心凹和中心凹周围解剖及肿瘤控制。
- 中心凹肿瘤眼解剖和功能结局较差,需权衡治疗获益与视觉潜能。
局限性
- 弱视治疗数据不足以评估其对视力影响,需前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To assess tumour control, vision and anatomical visual potential in eyes with perifoveal retinoblastoma treated by sequential photocoagulation from the antifoveal tumour edge inwards, avoiding treatment near the fovea. Patients were monitored for tumour control, foveal and perifoveal anatomy at each treatment session by optical coherence tomography (OCT) and treated for amblyopia when the other eye had better vision. METHODS: Eyes with perifoveal retinoblastoma treated between 1 January 2011 and 31 May 2017 with laser therapy after chemotherapy for juxtafoveal (fovea clear of tumour but <3000 µm from tumour edge) or foveolar retinoblastoma (tumour underlying fovea) were retrospectively reviewed for tumour control without recurrence, anatomical success (foveal pit preservation and/or restoration with ≥500 µm perifoveal retina free of tumour and scar) and functional success (acceptable (>0.1 decimal) or good (>0.3 decimal) visual acuity (VA)). RESULTS: Twenty-two eyes (14 juxtafoveal, 8 foveolar tumours) of 20 patients (19 bilateral, 1 familial and 11 females) were included. No juxtafoveal tumour had tumour recurrence, and 13/14 patients showed foveal pit preservation with ≥500 µm of perifoveal retina tumour free. Foveolar tumours had significant worse anatomical outcomes: failure to restore foveal pit or perifoveal retina (8/8, p=0.001) and tumour recurrences (5/8, p=0.001). Functional success with acceptable VA was achieved in 12/14 juxtafoveal and 5/8 foveal tumours eyes (p=0.01). Amblyopia therapy data were insufficient to evaluate impact on VA. CONCLUSIONS: Anatomical visual potential and functional vision were better in juxtafoveal than foveolar retinoblastoma treated with foveal-sparing laser photocoagulation guided by OCT. The role of amblyopia therapy requires a prospective study.
引用
- Soliman SE, VandenHoven C, Mackeen LD, et al. Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation. Br J Ophthalmol. 2018. PMID: 29976784. doi:10.1136/bjophthalmol-2018-312125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。